Should the dilated ascending aorta be repaired at the time of bicuspid aortic valve replacement?
File(s)ConcurBAV-AVR-TAAD251016Supple.docx (441.58 KB) ConcurBAV-AVR-TAAD251016.docx (1.1 MB)
Supporting information
Accepted version
Author(s)
Type
Journal Article
Abstract
OBJECTIVES
Bicuspid aortic valve (BAV) is the most common congenital valvular abnormality and frequently presents with accelerated calcific aortic valve disease, requiring aortic valve replacement (AVR) and thoracic aortic aneurysm and dissection. Supporting evidence for Association Guidelines of aortic dimensions for aortic resection is sparse. We sought to determine whether concurrent repair of dilated or aneurysmal aortic disease during AVR in patients with BAV substantially improves morbidity and mortality outcomes.
METHODS
Mortality and reoperation outcomes of 1301 adults with BAV and dilated aorta undergoing AVR-only surgery were compared to patients undergoing AVR with aortic resection (AVR-AR) using Cox proportional hazards modelling and patient matching.
RESULTS
Clinically important differences in patient characteristics, aortic valve function and aortic dimensions were identified between cohorts. Event rates were low, with rates of reoperation and death within 1 year of only 1.8% and 5.4%, respectively, and no aortic dissection observed during follow-up. There were no significant differences in reoperation or mortality outcomes between the AVR-only and AVR-AR cohorts. Age, aortic dimension or a combination thereof was not associated with better or worse outcomes after each AVR-AR compared with AVR.
CONCLUSIONS
We conclude AVR-only and AVR-AR surgery have low morbidity and mortality and have utility over a wide range of age and aortic sizes. Our results do not provide support for the 45-mm aortic dimension recommended in the current guidelines for aortic resection while performing AVR or any other specific dimension.
Bicuspid aortic valve (BAV) is the most common congenital valvular abnormality and frequently presents with accelerated calcific aortic valve disease, requiring aortic valve replacement (AVR) and thoracic aortic aneurysm and dissection. Supporting evidence for Association Guidelines of aortic dimensions for aortic resection is sparse. We sought to determine whether concurrent repair of dilated or aneurysmal aortic disease during AVR in patients with BAV substantially improves morbidity and mortality outcomes.
METHODS
Mortality and reoperation outcomes of 1301 adults with BAV and dilated aorta undergoing AVR-only surgery were compared to patients undergoing AVR with aortic resection (AVR-AR) using Cox proportional hazards modelling and patient matching.
RESULTS
Clinically important differences in patient characteristics, aortic valve function and aortic dimensions were identified between cohorts. Event rates were low, with rates of reoperation and death within 1 year of only 1.8% and 5.4%, respectively, and no aortic dissection observed during follow-up. There were no significant differences in reoperation or mortality outcomes between the AVR-only and AVR-AR cohorts. Age, aortic dimension or a combination thereof was not associated with better or worse outcomes after each AVR-AR compared with AVR.
CONCLUSIONS
We conclude AVR-only and AVR-AR surgery have low morbidity and mortality and have utility over a wide range of age and aortic sizes. Our results do not provide support for the 45-mm aortic dimension recommended in the current guidelines for aortic resection while performing AVR or any other specific dimension.
Date Issued
2018-03-01
Date Acceptance
2017-10-05
Citation
European Journal of Cardio-Thoracic Surgery, 2018, 53 (3), pp.560-568
ISSN
1010-7940
Publisher
Oxford University Press (OUP)
Start Page
560
End Page
568
Journal / Book Title
European Journal of Cardio-Thoracic Surgery
Volume
53
Issue
3
Copyright Statement
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved. This is a pre-copy-editing, author-produced version of an article accepted for publication in European Journal of Cardio-Thoracic Surgery following peer review. The definitive publisher-authenticated version is available online at: https://academic.oup.com/ejcts/article/53/3/560/4628127
Subjects
1102 Cardiorespiratory Medicine and Haematology
Respiratory System
Publication Status
Published
Date Publish Online
2017-11-14